Loading clinical trials...
Loading clinical trials...
An early-phase clinical trial evaluating the safety, tolerability, and pharmacokinetics of OM336 in adult participants with seropositive autoimmune diseases. OM336 is administered subcutaneously in as...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Ouro Medicines
NCT06991114 · Refractory Rheumatoid Arthritis (RA), Idiopathic Inflammatory Myopathies (IIMs), and more
NCT06888960 · Systemic Lupus Erythematosus (SLE), Idiopathic Inflammatory Myopathy (IIM), and more
NCT07085676 · Systemic Lupus Erythematosus (SLE), Systemic Sclerosis (SSc), and more
NCT06980597 · Systemic Lupus Erythematosus (SLE), Idiopathic Inflammatory Myopathy (IIM), and more
NCT06583395 · Amyotrophic Lateral Sclerosis (ALS), Angina, Stable, and more
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions